MA S1418 | 2023-2024 | 193rd General Court

Note: Legislation replaced by S2733

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 16 2023 - 25% progression
Action: 2024-04-22 - Accompanied a study order, see S2733
Text: Latest bill text (Introduced) [PDF]

Summary

For legislation to restore integrity in the marketing of pharmaceutical products and medical devices. Public Health.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

To restore integrity in the marketing of pharmaceutical products and medical devices

Sponsors


History

DateChamberAction
2024-04-22SenateAccompanied a study order, see S2733
2024-03-21SenateBill reported favorably by committee and referred to the Joint Committee on Health Care Financing
2023-05-26JointHearing scheduled for 06/06/2023 from 01:00 PM-05:00 PM in Gardner Auditorium
2023-02-16HouseHouse concurred
2023-02-16SenateReferred to the Joint Committee on Public Health

Same As/Similar To

S2733 (Replaced by) 2024-04-25 - Discharged to the committee on Senate Rules

Massachusetts State Sources


Bill Comments

feedback